Literature DB >> 27236600

MicroRNA signature of end-stage idiopathic pulmonary arterial hypertension: clinical correlations and regulation of WNT signaling.

Olivier Boucherat1,2, Sébastien Bonnet3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27236600     DOI： 10.1007/s00109-016-1431-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  15 in total

Review 1.  microRNA and Pulmonary Hypertension.

Authors:  Olivier Boucherat; François Potus; Sébastien Bonnet
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 2.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

3.  MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

Authors:  Victoria N Parikh; Richard C Jin; Sabrina Rabello; Natali Gulbahce; Kevin White; Andrew Hale; Katherine A Cottrill; Rahamthulla S Shaik; Aaron B Waxman; Ying-Yi Zhang; Bradley A Maron; Jochen C Hartner; Yuko Fujiwara; Stuart H Orkin; Kathleen J Haley; Albert-László Barabási; Joseph Loscalzo; Stephen Y Chan
Journal:  Circulation       Date:  2012-02-27       Impact factor: 29.690

4.  Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway.

Authors:  Ethan David Cohen; Kaori Ihida-Stansbury; Min Min Lu; Reynold A Panettieri; Peter Lloyd Jones; Edward E Morrisey
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

5.  Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.

Authors:  Danchen Wu; C Conover Talbot; Qun Liu; Zhi-Cheng Jing; Rachel L Damico; Rubin Tuder; Kathleen C Barnes; Paul M Hassoun; Li Gao
Journal:  J Mol Med (Berl)       Date:  2016-05-18       Impact factor: 4.599

Review 6.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

Review 7.  Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).

Authors:  François Potus; Colin Graydon; Steeve Provencher; Sébastien Bonnet
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 8.  Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Authors:  Rubin M Tuder; Stephen L Archer; Peter Dorfmüller; Serpil C Erzurum; Christophe Guignabert; Evangelos Michelakis; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Nicholas W Morrell
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

9.  Role for miR-204 in human pulmonary arterial hypertension.

Authors:  Audrey Courboulin; Roxane Paulin; Nellie J Giguère; Nehmé Saksouk; Tanya Perreault; Jolyane Meloche; Eric R Paquet; Sabrina Biardel; Steeve Provencher; Jacques Côté; Martin J Simard; Sébastien Bonnet
Journal:  J Exp Med       Date:  2011-02-14       Impact factor: 14.307

Review 10.  MicroRNAs in pulmonary arterial remodeling.

Authors:  Jennifer S Grant; Kevin White; Margaret R MacLean; Andrew H Baker
Journal:  Cell Mol Life Sci       Date:  2013-06-06       Impact factor: 9.261
View more
  3 in total

Review 1.  New and Emerging Therapies for Pulmonary Arterial Hypertension.

Authors:  Edda Spiekerkoetter; Steven M Kawut; Vinicio A de Jesus Perez
Journal:  Annu Rev Med       Date:  2018-09-14       Impact factor: 13.739

2.  Wnt5a is elevated in heart failure and affects cardiac fibroblast function.

Authors:  Aurelija Abraityte; Leif E Vinge; Erik T Askevold; Tove Lekva; Annika E Michelsen; Trine Ranheim; Katrine Alfsnes; Arnt Fiane; Svend Aakhus; Ida G Lunde; Christen P Dahl; Pål Aukrust; Geir Christensen; Lars Gullestad; Arne Yndestad; Thor Ueland
Journal:  J Mol Med (Berl)       Date:  2017-03-30       Impact factor: 4.599

Review 3.  Noncoding RNAs in Hypertension.

Authors:  Amela Jusic; Yvan Devaux
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.